Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Intentional infection of vulnerable populations in 1946-1948: another tragic history lesson.

Frieden TR, Collins FS.

JAMA. 2010 Nov 10;304(18):2063-4. doi: 10.1001/jama.2010.1554. Epub 2010 Oct 11. No abstract available.

2.
3.

An IRB member's perspective on access to innovative therapy.

Moore DL.

Albany Law Rev. 1994;57(3):559-81. No abstract available.

PMID:
11652854
4.

The Guatemala sexually transmitted disease studies: what happened.

Zenilman J.

Sex Transm Dis. 2013 Apr;40(4):277-9. doi: 10.1097/OLQ.0b013e31828abc1b. No abstract available.

PMID:
23486488
5.

Protection of human subjects.

U.S. Department of Health and Human Services.

Code Fed Regul Public Welfare. 1995 Oct 1;Title 45(Sections 46-101 to 46-409):Unknown. No abstract available.

PMID:
11686173
6.

To be or not to be: waiving informed consent in emergency research.

McCarthy CR.

Kennedy Inst Ethics J. 1995 Jun;5(2):155-62. No abstract available.

PMID:
10184356
7.

Regulating research on the terminally ill: a proposal for heightened safeguards.

Addicott DC.

J Contemp Health Law Policy. 1999 Spring;15(2):479-524. Review. No abstract available.

PMID:
10394764
8.

Wanted. Single, white male for medical research.

Dresser R.

Hastings Cent Rep. 1992 Jan-Feb;22(1):24-9. No abstract available.

PMID:
1544796
9.

Human subjects research with prisoners: putting the ethical question in context.

Obasogie OK, Reiter KA.

Bioethics. 2011 Jan;25(1):55-6. doi: 10.1111/j.1467-8519.2010.01859.x. No abstract available.

10.

A new rule for vulnerable research subjects has some special provisions.

[No authors listed]

Hum Res Rep. 1994 Jun;9(6):1-2. No abstract available.

PMID:
11654129
11.

Trends in the social control of medical and psychiatric research.

Benson PR, Roth LH.

Law Ment Health. 1988;4:1-47. Review. No abstract available.

PMID:
11655151
12.

Regulatory orphans: juvenile prisoners as transvulnerable research subjects.

Reed JG.

IRB. 1999 Mar-Apr;21(2):9-14. No abstract available.

PMID:
11657875
13.

Improving the decision processes of institutional review boards.

Wagner TH.

JAMA. 2004 Apr 14;291(14):1698; author reply 1698-9. No abstract available.

PMID:
15082694
14.

The legacy of sexually transmitted disease research: lessons from Guatemala and Dr. Thomas Parran: the American STD Association Distinguished Career Award Lecture.

Zenilman JM.

Sex Transm Dis. 2013 Dec;40(12):901-8. doi: 10.1097/OLQ.0000000000000063. No abstract available.

PMID:
24220348
15.

Vulnerable subjects and civic professionalism: would six-sigma research and research ethics consultation solve the vulnerability problem?

Marshall MF.

Am J Bioeth. 2004 Summer;4(3):54-5; discussion W32. No abstract available.

PMID:
16192141
16.

Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.

Maloney DM.

Hum Res Rep. 2003 Jun;18(6):6-7. No abstract available.

PMID:
15119342
17.

[Pediatric research is necessary. The children must be guaranteed with a complete protection].

Dahlquist G.

Lakartidningen. 2004 Jun 24;101(26-27):2238-9. Swedish. No abstract available.

PMID:
15281622
18.

The changing clinical trials scene: the role of the IRB.

Mitchell SC, Steingrub J.

IRB. 1988 Jul-Aug;10(4):1-5. No abstract available.

PMID:
11650078
19.

Forum on prisoners' access to clinical trials: summary of recommendations.

Stein GL, Headley LD.

AIDS Public Policy J. 1996 Spring;11(1):3-20. No abstract available.

PMID:
10915234
20.

The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.

Weijer C.

IRB. 1998 Mar-Jun;20(2-3):1-5. No abstract available.

PMID:
11656912

Supplemental Content

Support Center